Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fortunato Morabito

Showing results (161-170 of 302) with videos related to

Pageof 31
Sort By:
Clinical and Translational Medicine|March 7, 2026
Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapyEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|March 15, 2026
Ph-Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet NeedsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Cells|July 13, 2026
Ferroptosis in Lymphoproliferative DisordersSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology|December 26, 2025
Chemotherapy-Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune-Based ApproachesEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|February 6, 2026
Targeting Ikaros and Aiolos: Next-Generation Cereblon E3 Ligase Modulators in MMMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
Journal of Geriatric Oncology|March 9, 2025
Frailty predicts treatment-related toxicity and discontinuation in older adults with chronic lymphocytic leukemia treated with BTK and BCL-2 inhibitors: Findings from a prospective single-center cohort studyEnrica Antonia Martino, Ernesto Vigna, Paola De Luca, et al.
British Journal of Haematology|June 15, 2026
Minimal residual disease in diffuse large B-cell lymphoma after first-line therapy: Defining the continuum from metabolic remission to molecular clearanceSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Haematologica|February 13, 2008
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up studyStefano Sacchi, Luigi Marcheselli, Alessia Bari, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 24, 2018
Efficacy of eculizumab in severe ADAMTS13-deficient thrombotic thrombocytopenic purpura (TTP) refractory to standard therapiesErnesto Vigna, Annamaria Petrungaro, Anna Perri, et al.
Expert Opinion on Pharmacotherapy|November 19, 2019
An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphomaFortunato Morabito, Anna Grazia Recchia, Ernesto Vigna, et al.
Pageof 31

Showing results (161-170 of 302) with videos related to

Sort By:
Pageof 31
Clinical and Translational Medicine|March 7, 2026
Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapyEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|March 15, 2026
Ph-Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet NeedsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Cells|July 13, 2026
Ferroptosis in Lymphoproliferative DisordersSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology|December 26, 2025
Chemotherapy-Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune-Based ApproachesEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|February 6, 2026
Targeting Ikaros and Aiolos: Next-Generation Cereblon E3 Ligase Modulators in MMMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
Journal of Geriatric Oncology|March 9, 2025
Frailty predicts treatment-related toxicity and discontinuation in older adults with chronic lymphocytic leukemia treated with BTK and BCL-2 inhibitors: Findings from a prospective single-center cohort studyEnrica Antonia Martino, Ernesto Vigna, Paola De Luca, et al.
British Journal of Haematology|June 15, 2026
Minimal residual disease in diffuse large B-cell lymphoma after first-line therapy: Defining the continuum from metabolic remission to molecular clearanceSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Haematologica|February 13, 2008
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up studyStefano Sacchi, Luigi Marcheselli, Alessia Bari, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 24, 2018
Efficacy of eculizumab in severe ADAMTS13-deficient thrombotic thrombocytopenic purpura (TTP) refractory to standard therapiesErnesto Vigna, Annamaria Petrungaro, Anna Perri, et al.
Expert Opinion on Pharmacotherapy|November 19, 2019
An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphomaFortunato Morabito, Anna Grazia Recchia, Ernesto Vigna, et al.
Pageof 31